0001209191-22-031402.txt : 20220523
0001209191-22-031402.hdr.sgml : 20220523
20220523175312
ACCESSION NUMBER: 0001209191-22-031402
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220523
FILED AS OF DATE: 20220523
DATE AS OF CHANGE: 20220523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenway Schond L.
CENTRAL INDEX KEY: 0001848205
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40360
FILM NUMBER: 22953091
MAIL ADDRESS:
STREET 1: C/O CERECOR, INC.
STREET 2: 540 GAITHER ROAD, SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc.
CENTRAL INDEX KEY: 0001813814
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1166 ALBERNI STEET
STREET 2: SUITE 1604
CITY: VANCOUVER
STATE: A1
ZIP: V6E 3Z3
BUSINESS PHONE: (212) 220-6633
MAIL ADDRESS:
STREET 1: 1166 ALBERNI STEET
STREET 2: SUITE 1604
CITY: VANCOUVER
STATE: A1
ZIP: V6E 3Z3
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-23
0
0001813814
Mind Medicine (MindMed) Inc.
MNMD
0001848205
Greenway Schond L.
C/O MIND MEDICINE (MINDMED), INC.
ONE WORLD TRADE CENTER, SUITE 8500
NEW YORK
NY
10007
0
1
0
0
Chief Financial Officer
Subordinate Voting Shares
2022-05-23
4
A
0
1270000
0.00
A
1270000
D
Stock Option (Right to Buy)
0.71
2022-05-23
4
A
0
1650000
0.00
A
2027-05-22
Subordinate Voting Shares
1650000
1650000
D
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, 25% shall vest on May 23, 2023 with 1/12th of the remaining shares vesting each quarter thereafter over 12 quarters, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
The option grant has an exercise price of $0.91 Canadian Dollars. This represents the exercise price in United States Dollars.
The shares subject to the option vest and become exercisable, with 25% vesting on May 23, 2023, and 1/36th of the remaining shares vesting monthly thereafter over 36 months, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date.
/s/ Schond L. Greenway
2022-05-23